About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,618 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,618 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1821-1840 of 6,618 trials

UnknownStudy of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood TransplantationThe goal of this clinical research study is to learn if it is safe and feasible to transplant patients with one of two units of cord blood that has been changed in the laboratory…NCT01983761·La Jolla, California and 3 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

CompletedA Disease Registry of Patients With Mantle Cell LymphomaThe purpose of this study is to create a patient registry in order to assess treatment patterns, physician reported clinical outcomes and patient-reported health-related quality…NCT03816683·Montgomery, Alabama and 31 others

CompletedVaccine Therapy Plus Interleukin-2 in Treating Patients With Stage III, Stage IV, or Recurrent Follicular LymphomaRATIONALE: Vaccines made from a person's cancer cells may make the body build an immune response to kill tumor cells.NCT00020462·Bethesda, Maryland

Active not recruitingUltra Low Dose Radiation Therapy in Treating Patients With Mycosis FungoidesThis phase II trial studies how well ultra low dose radiation therapy works in treating patients with mycosis fungoides.NCT03398161·Houston, Texas

UnknownBiofeedback Training's Impact on Cognitive and Motor Skills in Kids With Intellectual DisabilitiesThe expected outcome of the study is to confirm or reject the hypothesis that traditional rehabilitation in combined with biofeedback training produces better results in improving…NCT06120686·Rzeszów

TerminatedA Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesThe purpose of this study is to evaluate the safety, tolerability, dose-limiting toxicities (any harmful effect of a drug) (DLT), maximum tolerated dose (MTD), recommended Phase 2…NCT02454270·Detroit, Michigan and 19 others

Active not recruitingAntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin LymphomaThe purpose of this study is to determine if it is possible to treat your cancer with a new type of T cell-based immunotherapy (therapy that uses your immune system to treat the…NCT03434769·St Louis, Missouri and 1 other

CompletedTreatment of Mycosis Fungoides With Hypericin Ointment and Visible LightThe goal of this clinical trial is to assess the benefit of continuous treatment with synthetic hypericin ointment (HyBryte) and visible light in patients with mycosis fungoides…NCT05872854·Philadelphia, Pennsylvania

CompletedThe Effectiveness of Alemtuzumab Given in Combination With CHOP and ESHAP in Patients Newly Diagnosed With Peripheral T-Cell Lymphoma (PTCL)1.NCT00930605·Bangkok

UnknownAnti-PD-1 Antibody and Pegaspargase Combined With Radiotherapy in Early-Stage ENKTLAim of the trial is to evaluate the safety and efficacy of sintilimab and pegaspargase in combination with pegaspargase for the initial treatment of previously untreated patients…NCT04676789·Guangzhou, Please Select

CompletedMalaria Vaccine in Children in MaliThis study will test an experimental vaccine called AMA1-C1 in children to see if it is safe and if it reduces episodes of malaria parasitemia (parasites in the blood) in children…NCT00341250·Bankoumana and 1 other

CompletedAZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHLThis is a modular dose confirmation and expansion study.NCT05140382·Duarte, California and 26 others

UnknownStudy Evaluating the Safety and Efficacy of JWCAR029 in Adult Subjects With Relapsed and Refractory B-cell Non-Hodgkin LymphomaThis is a single arm, open-label, dose escalation clinical study to evaluate the safety and efficacy of infusion of autologous CD19-targeted chimeric antigen receptor (CD19 CAR) T…NCT03355859·Shanghai, Shanghai Municipality

CompletedPhase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin LymphomaR-CHOP with doxorubicin is the standard first line treatment of high grade non-Hodgkin's lymphoma.NCT01958996·Poitiers

UnknownStudy of Welgenaleucel (UWC19) in Patients With Relapsed or Refractory B-cell LymphomaThis is an open-label, single-center Phase 1/2 study with a dose-escalation phase (Part 1) and a cohort expansion phase (Part 2) in patients with relapsed or refractory (R/R)…NCT04296461·Taipei

RecruitingSequential Treatment of CD19 CARNK and 7x19 CAR-T in R/R B Cell LymphomaTo study the safety and efficacy of cord blood-derived CD19 CAR-NK cells sequential with 7x19 CAR-T in relapse / refractory B cell lymphomaNCT06464861·Hangzhou, Zhejiang

CompletedDasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryThis phase I trial studies the side effects and best dose of dasatinib in treating patients with solid tumors or lymphomas that are metastatic or cannot be removed by surgery.NCT00608361·Duarte, California and 22 others

TerminatedRituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHLThe purpose of this study is to determine the optimal dose of subcutaneous CAMPATH when used in combination with rituximab for patients with relapsing or refractory, low-grade or…NCT00077961·Colorado Springs, Colorado and 9 others

TerminatedIn-Vivo Activated T-Cell Depletion to Prevent GVHDThe purpose of this study is to compare the effects (good and bad) of the medication basiliximab in combination with cyclosporine with cyclosporine alone for the prevention of…NCT00594308·Indianapolis, Indiana

TerminatedStudy to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)This study will evaluate the safety and efficacy of favezelimab (MK-4280) in combination with pembrolizumab (MK-3475) using a non-randomized study design in participants with the…NCT03598608·Gilbert, Arizona and 24 others

PreviousPage 92 of 331Next